Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious, and other diseases.

 
 
 
 

Contacts


Company Contact:

Sarepta Therapeutics Headquarters
215 First Street
Cambridge, MA 02142
info@sarepta.com
617.274.4000

Sarepta Therapeutics Corvallis
4575 SW Research Way
Suite 200
Corvallis, OR 97333



Investor & Press Contact:

investors@sarepta.com
617.274.4080

media@sarepta.com
617.274.4052



Transfer Agent:

Shareholders of record with questions about lost certificates, notification of change of address, or other matters may send correspondence to:

Computershare
P.O. Box 43006
Providence, RI 02940-3006

Overnight correspondence should be mailed to:

Computershare
250 Royall Street
Canton, MA 02021

Dedicated toll free: 877.238.2973
Foreign Shareholders: 201.680.6578
TDD Foreign Shareholders: 201.680.6610
Investor Center: computershare.com/investor
Shareholder Online Inquiries: computershare.com/investor